Artificial Intelligence driven personalized treatments is the fastest growing segment fueling the growth of T-cell Lymphoma market
T-cell Lymphoma Market The global T-cell Lymphoma Market is estimated to be valued at US$ 1961.64 Mn in 2023 and is expected to exhibit a CAGR of 9.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: T-cell lymphoma is a type of cancer that affects lymphocytes called T cells in the immune system. The treatment options available in the market include chemotherapy, radiation therapy, stem cell transplantation, targeted therapy and others. These treatment help in killing or slowing the growth of cancer cells in the body. Market key trends: Artificial intelligence is being used in developing personalized treatments for cancer. Through machine learning algorithms, AI analyzes a patient's genetic information and determines the most suitable and effective treatment plan. It also helps in monitoring the disease progression and modifying treatment accordingly. Researchers are working on developing AI power...